|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| 08-04 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-04 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
Performance
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% | ||
| 1 year | +49.52% | ||
| 3 years | -20.18% | ||
| 5 years | +107.02% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (GBX)
4,570,668,625
Market Cap (USD)
4,570,668,625
Net sales (USD)
1,239,000,000
Free-Float
97.99 %
Free-Float capitalization (GBX)
4,478,596,997
Free-Float capitalization (USD)
4,478,596,997
Indicators
Moving average 5 days
1,202.2
Moving average 100 days
895.46
Price spread / (MMA5)
-2.89%
Price spread / (MMA100)
-27.67%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +5.27% | +49.52% | -20.18% | 4.57B | |
| +0.73% | +1.92% | +57.72% | +159.24% | 1,043B | |
| -0.43% | +0.08% | +50.08% | +47.91% | 621B | |
| -1.26% | -5.78% | +23.55% | +61.33% | 435B | |
| 0.00% | +3.20% | +46.70% | +37.70% | 361B | |
| +0.58% | -1.26% | +35.52% | +39.32% | 293B | |
| -1.55% | -6.84% | +7.20% | +8.86% | 251B | |
| -1.27% | +3.69% | +41.20% | +58.91% | 220B | |
| -0.24% | -11.27% | +1.42% | -46.20% | 201B | |
| -1.78% | -1.58% | +17.16% | +60.16% | 164B | |
| Average | -0.54% | -3.81% | +33.01% | +40.70% | 359.37B | |
| Weighted average by Cap. | -0.24% | -3.79% | +39.79% | +73.27% |
Historical Quotes: Indivior Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 1,160 |  | 1,264 |
| 1 month | 975.5 | | 1,264 |
| 3 years | 554.83 | | 2,020 |
| 5 years | 335 | | 2,020 |
Monthly variations
Annual variations
| 2025 | -.--% | ||
| 2025 | +20.90% | ||
| 2024 | -13.59% | ||
| 2023 | -36.02% | ||
| 2022 | +44.12% | ||
| 2021 | +136.21% | ||
| 2020 | +178.97% | ||
| 2019 | -65.29% | ||
| 2018 | -72.48% | ||
| 2017 | +37.81% | ||
| 2016 | +57.72% | ||
| 2015 | +25.70% |
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
- Quotes Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
